Results & Expectations
    Retatrutide

    Retatrutide Before and After: 71 Pounds

    Seventy-one pounds. That is roughly what a participant at the highest retatrutide dose lost on average in Phase 2 -- a transformation that changed not just a number on the scale, but an entire health trajectory.

    Published: April 3, 202613 min read

    Numbers in clinical trials can feel abstract. "24% body weight loss" is a statistic. But 71 pounds is a person who no longer avoids mirrors. It is a closet of clothes that no longer fits -- because they are all too big. It is a set of stairs that no longer requires rest halfway up. It is a blood sugar reading that no longer says "diabetic." Phase 2 of the retatrutide trial (Jastreboff et al., NEJM 2023) produced these transformations routinely at the highest dose, and Phase 3 will determine whether they hold up across thousands of patients.

    Data Context

    The 71-pound figure is approximate, based on 24% average weight loss at the highest dose for a participant starting around 296 pounds. Individual results vary significantly. Clinical trials do not publish individual before/after photos. Retatrutide is investigational.

    The Timeline of Transformation

    Seventy-one pounds did not disappear overnight. It accumulated over 48 weeks of consistent treatment. Months 1-2: the first 10-15 pounds, mostly noticed by the patient as looser clothing and a lighter feeling. Months 3-4: 25-35 cumulative pounds lost, noticeable to friends and family. Months 5-8: 45-60 cumulative pounds, dramatic visual transformation requiring new wardrobe. Months 9-12: approaching 71 pounds, the person in the mirror is substantially different from the person who started.

    Health Transformation Beyond Appearance

    The metabolic transformation that accompanies 71 pounds of weight loss is arguably more important than the visual change. Type 2 diabetes markers improve dramatically -- many patients achieve near-normal HbA1c levels, some potentially reaching remission criteria. Blood pressure often normalizes without medication. Liver fat drops by 80%+ thanks to glucagon-driven hepatic fat oxidation. Sleep apnea resolves or dramatically improves. Joint pain decreases as mechanical load drops. Inflammatory markers normalize. The cardiovascular risk profile shifts from high-risk to substantially lower risk.

    What 71 Pounds Looks Like in Daily Life

    • Climbing stairs without breathlessness
    • Fitting into airplane seats comfortably
    • Playing with children or grandchildren without limitation
    • Reduced or eliminated daily medications
    • Improved confidence and social engagement
    • Better sleep quality and more energy throughout the day
    • Ability to exercise that was not possible before

    Setting Your Own "Before and After"

    Your transformation may be 71 pounds, or 40, or 90. The exact number matters less than the direction. Every pound of fat lost improves metabolic health, reduces disease risk, and enhances quality of life. The goal is not perfection -- it is meaningful, sustained improvement that changes your health trajectory.

    To start your own transformation, visit our treatments page.

    Medical Disclaimer

    This article is for educational purposes only. Retatrutide is not FDA-approved. The 71-pound figure is an estimate from Phase 2 data (Jastreboff et al., NEJM 2023). Individual results vary. No individual patient photos from clinical trials are included or endorsed. Consult a healthcare provider.

    Write Your Own Transformation Story

    Start today. Semaglutide from $99/mo, tirzepatide from $125/mo.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 5, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    What to expect in your first month on retatrutide: realistic weight loss expectations, side effects, appetite changes, and tips for maximizing early results during the dose titration phase.

    Planning pregnancy while on semaglutide or tirzepatide? Essential guide to washout periods, fertility effects, and safely transitioning off GLP-1 medications before conception.

    Should you try compounded retatrutide before FDA approval? Understanding the legal risks, safety concerns, and why medical experts recommend waiting for approved options.

    Is retatrutide safe? Review all Phase 2 clinical trial safety data including side effects, serious adverse events, discontinuation rates, and what we know about the triple-agonist